Cognetivity Neurosciences Ltd
@Cognetivity
Followers
813
Following
919
Media
147
Statuses
741
Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's
London, England
Joined September 2017
#CognICA Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service #NHS:..@FrontPubHealth
1
1
0
Our Latest PeerReviewed Study Highlights Cost-Efficiency and Improved Clinical Outcomes From Using #CognICA, Showing Savings of Over £40 Million Per Year Compared With Traditional #CognitiveAssessment Tools in Primary and Secondary Care. #HealthEconomics.
0
1
2
RT @InterSystemsUKI: Today marks #WorldAlzheimersDay. We’re proud of our partner @Cognetivity who are making major advancements in the #dem….
0
1
0
📣 Exciting Partnership Announcement on World Alzheimer's Day!.Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology .#WorldAlzheimersDay #Cognetivity #NoFearCounselling.
0
0
3
RT @SKhaligh: Excited to share our latest Publication! We explored how the Integrated Cognitive Assessment (ICA) can improve primary care r….
frontiersin.org
Current primary care cognitive assessment tools are either crude or time-consuming instruments that can only detect cognitive impairment when it is well esta...
0
5
0
New Disease Modifying Drug for Alzheimer’s Disease Approved by FDA, Crucial Role for Cognetivity -
0
1
0
This is a great opportunity to enhance the benefits of early intervention and personalized care, ultimately promoting brain health, well-being, and improved quality of life. #CognetivityNeurosciences #CognICA #Alzheimers #Lecanemab .
1
0
0
Following the approval of Leqembi, a breakthrough drug to treat Alzheimer's, our AI technology is positioned to provide crucial real-world evidence for the drug's effectiveness. As a result, our technology is well-positioned to provide the necessary basis for reimbursement by CMS.
1
2
2
Cognetivity Partners with Clairvo to Advance AI Powered Brain Health Management in Japan -
0
3
2
Cognetivity to Play Pivotal Role in Delivery of New Alzheimer's Drugs -
1
0
2
Cognetivity Announces Collaboration with Alzheimer's Society -
0
1
1
Eli Lilly releases positive results on latest drug for Alzheimer’s disease -
0
0
1
Eli Lilly releases positive results on latest drug for Alzheimer’s disease -
0
0
1
Cognetivity Neurosciences Announces Agreement With Japanese Life Insurance Company -
0
3
5
Cognetivity Neurosciences Appoints Renowned Life Sciences Leader -
0
0
2
Cognetivity Unveils Groundbreaking Research on Cognition and Sleep - Extends Collaboration with University of Oxford -
0
1
1
Cognetivity Enters Commercial Agreement with UK-Based Brain Health Supplements Provider -
0
0
3
Cognetivity Publishes Outstanding Results & Expands Deployment With Senior Care Network in Singapore -
0
0
1